Lipidor is an early stage medtech company with a novel approach to drug formulation and delivery using lipids. Lipidor AB was established in 2009 to capitalize on the founders’ extensive experience with lipids and product development. Lipidor’s activities are focused on exploring how lipids can be used in combination with substances and materials not traditionally associated with lipids. The company patents its discoveries with the intention of commercial development in collaboration with other interested parties. Lipidor is owned by its founders and Karolinska Development AB.